The synthesis and structure–activity relationships (SAR) of novel, potent imidazo [1, 2-a] pyrazine-based Aurora kinase inhibitors are described. The X-ray crystal structure of imidazo [1, 2-a] pyrazine Aurora inhibitor 1j is disclosed. Compound 10i was identified as lead compound with a promising overall profile.